JP2016116523A5 - - Google Patents

Download PDF

Info

Publication number
JP2016116523A5
JP2016116523A5 JP2016000288A JP2016000288A JP2016116523A5 JP 2016116523 A5 JP2016116523 A5 JP 2016116523A5 JP 2016000288 A JP2016000288 A JP 2016000288A JP 2016000288 A JP2016000288 A JP 2016000288A JP 2016116523 A5 JP2016116523 A5 JP 2016116523A5
Authority
JP
Japan
Prior art keywords
adipose tissue
derived stromal
stromal stem
stem cells
markers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016000288A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016116523A (ja
JP6545624B2 (ja
Filing date
Publication date
Priority claimed from US11/167,061 external-priority patent/US20060045872A1/en
Application filed filed Critical
Publication of JP2016116523A publication Critical patent/JP2016116523A/ja
Publication of JP2016116523A5 publication Critical patent/JP2016116523A5/ja
Application granted granted Critical
Publication of JP6545624B2 publication Critical patent/JP6545624B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016000288A 2005-06-24 2016-01-04 瘻の治療における脂肪組織由来間質幹細胞の使用 Expired - Fee Related JP6545624B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/167,061 US20060045872A1 (en) 2004-08-25 2005-06-24 Use of adipose tissue-derived stromal stem cells in treating fistula
US11/167,061 2005-06-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013218552A Division JP6289858B2 (ja) 2005-06-24 2013-10-21 瘻の治療における脂肪組織由来間質幹細胞の使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019018275A Division JP6812475B2 (ja) 2005-06-24 2019-02-04 瘻の治療における脂肪組織由来間質幹細胞の使用

Publications (3)

Publication Number Publication Date
JP2016116523A JP2016116523A (ja) 2016-06-30
JP2016116523A5 true JP2016116523A5 (enExample) 2016-10-20
JP6545624B2 JP6545624B2 (ja) 2019-07-17

Family

ID=37116048

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2008517346A Pending JP2008546397A (ja) 2005-06-24 2006-05-16 瘻の治療における脂肪組織由来間質幹細胞の使用
JP2013218552A Active JP6289858B2 (ja) 2005-06-24 2013-10-21 瘻の治療における脂肪組織由来間質幹細胞の使用
JP2016000288A Expired - Fee Related JP6545624B2 (ja) 2005-06-24 2016-01-04 瘻の治療における脂肪組織由来間質幹細胞の使用
JP2019018275A Active JP6812475B2 (ja) 2005-06-24 2019-02-04 瘻の治療における脂肪組織由来間質幹細胞の使用
JP2020088068A Active JP7027484B2 (ja) 2005-06-24 2020-05-20 瘻の治療における脂肪組織由来間質幹細胞の使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2008517346A Pending JP2008546397A (ja) 2005-06-24 2006-05-16 瘻の治療における脂肪組織由来間質幹細胞の使用
JP2013218552A Active JP6289858B2 (ja) 2005-06-24 2013-10-21 瘻の治療における脂肪組織由来間質幹細胞の使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019018275A Active JP6812475B2 (ja) 2005-06-24 2019-02-04 瘻の治療における脂肪組織由来間質幹細胞の使用
JP2020088068A Active JP7027484B2 (ja) 2005-06-24 2020-05-20 瘻の治療における脂肪組織由来間質幹細胞の使用

Country Status (23)

Country Link
US (10) US20060045872A1 (enExample)
EP (7) EP2944688B1 (enExample)
JP (5) JP2008546397A (enExample)
KR (1) KR20080036588A (enExample)
CN (2) CN101263224A (enExample)
AU (1) AU2006261383B2 (enExample)
BR (1) BRPI0613811B8 (enExample)
CA (1) CA2613457C (enExample)
CY (3) CY1116764T1 (enExample)
DK (4) DK2944688T3 (enExample)
ES (6) ES2880349T3 (enExample)
HU (3) HUE025338T2 (enExample)
IL (1) IL188378A (enExample)
LT (3) LT3176255T (enExample)
LU (1) LUC00085I2 (enExample)
NL (1) NL300953I2 (enExample)
NZ (2) NZ565246A (enExample)
PL (3) PL3176255T3 (enExample)
PT (3) PT2292737E (enExample)
RU (3) RU2435846C2 (enExample)
SG (1) SG166770A1 (enExample)
SI (3) SI3176255T1 (enExample)
WO (1) WO2006136244A2 (enExample)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8455458B2 (en) 2002-10-16 2013-06-04 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage
US7803787B2 (en) * 2002-10-16 2010-09-28 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage by transmucosal administration
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
WO2006121792A2 (en) 2005-05-05 2006-11-16 Archipelago Holdings, Inc. Unpriced order auction and routing
US20070027543A1 (en) * 2005-08-01 2007-02-01 Gimble Jeffrey M Use of adipose tissue-derived stromal cells in spinal fusion
MX342474B (es) * 2005-09-23 2016-09-30 Cellerix Sl Poblaciones celulares con actividad inmunoreguladora, método de aislamiento y usos.
US20100322906A1 (en) * 2005-10-05 2010-12-23 Osaka University Method for Obtaining Pancreatic Endocrine Cells From Adipose Tissue-Origin Cells
AU2006320507B2 (en) * 2005-12-02 2012-11-01 Cook Medical Technologies Llc Devices, systems, and methods for occluding a defect
US20090209031A1 (en) * 2006-01-26 2009-08-20 Tyco Healthcare Group Lp Medical device package
WO2007089798A2 (en) * 2006-01-30 2007-08-09 University Of Virginia Patent Foundation Methods of preparing and characterizing mesenchymal stem cell aggregates and uses thereof
US20070224173A1 (en) * 2006-03-21 2007-09-27 Koullick Edouard A Nonexpansion Protocol for Autologous Cell-Based Therapies
US8021882B2 (en) 2006-08-24 2011-09-20 Johnstone Brian H Production of neural protective and regenerative factors from stem cells and treatment of nervous system conditions therewith
AU2007320031B2 (en) * 2006-10-06 2013-05-02 University Of Virginia Patent Foundation Methods and compositions useful for diabetic wound healing
KR20080103637A (ko) * 2007-05-25 2008-11-28 주식회사 알앤엘바이오 지방유래 줄기세포를 함유하는 사지말단부 허혈성 질환의세포치료용 조성물
US9186375B2 (en) 2007-06-21 2015-11-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan compositions in combination with stem cells
AU2014227541B2 (en) * 2007-09-19 2015-10-01 Pluristem Ltd. Methods of Treating Inflammatory Colon Diseases
WO2009144720A1 (en) * 2008-05-27 2009-12-03 Pluristem Ltd. Methods of treating inflammatory colon diseases
US9144584B2 (en) * 2008-06-11 2015-09-29 Cell4Vet Corporation Adipose tissue-derived stem cells for veterinary use
KR101712560B1 (ko) 2008-06-24 2017-03-06 바이오엑티브 써지컬, 아이엔씨. 줄기 세포 또는 기타 생활성 물질이 혼입된 수술용 봉합사
US20100098739A1 (en) * 2008-10-20 2010-04-22 University Of Virginia Patent Foundation Compositions and methods for modular soft tissue repair
US20100112696A1 (en) * 2008-11-03 2010-05-06 Baxter International Inc. Apparatus And Methods For Processing Tissue To Release Cells
US8309343B2 (en) 2008-12-01 2012-11-13 Baxter International Inc. Apparatus and method for processing biological material
DK2425844T3 (da) * 2009-04-28 2014-06-16 Anterogen Co Ltd Autolog og allogen stromastamcellesammensætning, der stammer fra fedtvæv, til behandling af fistler
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9669200B2 (en) 2010-08-06 2017-06-06 Boston Scientific Scimed, Inc. Systems and methods for the treatment of pelvic disorders including magnetic particulates
US20120087933A1 (en) 2010-10-08 2012-04-12 Samson Tom Enhanced msc preparations
US9180172B2 (en) 2010-12-15 2015-11-10 Ams Research Corporation Treatment of Peyronies disease
US8979797B2 (en) 2010-12-16 2015-03-17 Ams Research Corporation High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
WO2012095743A2 (en) 2011-01-12 2012-07-19 Cellerix Sa Methods and compositions for use in intralymphatic cellular therapies
WO2012123401A1 (en) 2011-03-11 2012-09-20 Tigenix, S.A. Cell populations having immunoregulatory activity, method for isolation and uses
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
CL2011001904A1 (es) * 2011-08-08 2012-03-09 Univ Pontificia Catolica Chile Formulacion farmaceutica que comprende celulas madres mesenquimales vivas suspendidas en un vehiculo farmaceuticamente aceptable, sistema de aplicacion topica en aerosol que las comprende; y su uso para tratar heridas.
US20130072903A1 (en) * 2011-09-20 2013-03-21 John Chapman Adipose Tissue Graft for Wound Healing
GB201202319D0 (en) * 2012-02-10 2012-03-28 Orbsen Therapeutics Ltd Stromal stem cells
US20140024011A1 (en) * 2012-07-23 2014-01-23 AdiCyte, Inc. Method for Preparing Adipose Tissue
EP3473276B1 (en) * 2012-10-18 2023-12-13 Mayo Foundation for Medical Education and Research Techniques for treatment of abscesses
WO2014186854A1 (pt) * 2013-05-24 2014-11-27 Universidade Estadual De Campinas - Unicamp Processo de obtenção de fio de sutura enriquecido com celulas-tronco, fios obtidos, kit de sutura e seus usos
CA2919374C (en) 2013-07-30 2019-12-03 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
WO2016086147A1 (en) * 2014-11-26 2016-06-02 Millennium Pharmaceuticals, Inc. Vedolizumab for the treatment of fistulizing crohn's disease
RU2588835C1 (ru) * 2014-11-27 2016-07-10 Олег Германович Макеев Способ терапии повреждений кожи и биотрансплантат для его осуществления
CA3177726A1 (en) 2015-05-21 2016-11-24 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
US12433916B2 (en) 2015-10-23 2025-10-07 Rigshospitalet Cell bank of high concentration adipose-derived stem cell composition and related methods
GB201604304D0 (en) * 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
US11389470B2 (en) * 2016-07-12 2022-07-19 Centre National De La Recherche Scientifique Compositions useful for mucosal healing
IT201700043316A1 (it) * 2017-04-20 2018-10-20 Lipogems Int S P A Drug delivery system
JP6999918B2 (ja) * 2017-08-21 2022-02-04 学校法人慶應義塾 血小板表面抗原と間葉系細胞表面抗原を共発現する血小板様細胞を含む創傷治癒促進剤
AU2018372631B2 (en) 2017-11-22 2025-06-05 Mesoblast International Sarl Cellular compositions and methods of treatment I
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
CN111840645B (zh) * 2020-07-29 2022-04-01 沈阳细胞治疗工程技术研发中心有限公司 一种瘘洞修补制剂及其制备方法
KR102827440B1 (ko) * 2020-12-24 2025-07-03 주식회사 로킷헬스케어 조직 재생 패치의 제조방법
CN114949361A (zh) * 2021-12-31 2022-08-30 浙江金时代生物技术有限公司 一种用于子宫内膜修复的聚乳酸-羟基乙酸共聚物支架与人脐带间充质干细胞复合物的制备方法
EP4704869A2 (en) * 2023-04-28 2026-03-11 Angiocrine Bioscience, Inc. Endothelial cells for treatment of gastrointestinal fistula

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298002A (en) 1979-09-10 1981-11-03 National Patent Development Corporation Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue and methods of preparation
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5143842A (en) 1988-11-01 1992-09-01 The University Of Colorado Foundation, Inc. Media for normal human muscle satellite cells
US5145770A (en) 1990-06-04 1992-09-08 Biosurface Technology, Inc. Cryopreservation of cultured epithelial sheets
US5149543A (en) 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules
US5733542A (en) 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
US6010696A (en) * 1990-11-16 2000-01-04 Osiris Therapeutics, Inc. Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
DE59307956D1 (de) 1992-10-10 1998-02-12 Hemscheidt Fahrwerktech Gmbh Hydropneumatisches federungssystem
AU673877B2 (en) 1992-12-02 1996-11-28 Shell Internationale Research Maatschappij B.V. Azoxycyanobenzene derivatives
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5578475A (en) 1993-07-12 1996-11-26 Life Technologies, Inc. Composition and methods for transfecting eukaryotic cells
CA2192103C (en) 1994-06-06 2002-02-05 Arnold I. Caplan Biomatrix for tissue regeneration
US6174333B1 (en) 1994-06-06 2001-01-16 Osiris Therapeutics, Inc. Biomatrix for soft tissue regeneration using mesenchymal stem cells
ATE285477T1 (de) 1995-06-07 2005-01-15 Inex Pharmaceutical Corp Herstellung von lipid-nukleinsäure partikeln duch ein hydrophobische lipid-nukleinsäuree komplexe zwischenprodukt und zur verwendung in der gentransfer
US6051429A (en) 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
US6030833A (en) 1995-08-04 2000-02-29 The General Hospital Transgenic swine and swine cells having human HLA genes
US5744335A (en) 1995-09-19 1998-04-28 Mirus Corporation Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
US5705308A (en) 1996-09-30 1998-01-06 Eastman Kodak Company Infrared-sensitive, negative-working diazonaphthoquinone imaging composition and element
WO1998031316A1 (en) * 1997-01-17 1998-07-23 Celadon Science, Llc Methods for promoting healing of corneal resurfacing wounds
ES2351082T3 (es) 1997-12-02 2011-01-31 Artecel Sciences, Inc. Diferenciación de células estromales adiposas en osteoblastos y sus usos.
ATE265220T1 (de) 1998-02-04 2004-05-15 Gen Hospital Corp Kostimulatorische blockade und gemischter chimerismus in allotransplantationen
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US9585916B2 (en) 1999-03-26 2017-03-07 Northern Therapeutics Inc. Cell based therapy for the pulmonary system
US6797269B2 (en) 1998-04-03 2004-09-28 Osiris Therapeutics, Inc. Mesenchymal stem cells as immunosuppressants
US6546105B1 (en) 1998-10-30 2003-04-08 Matsushita Electric Industrial Co., Ltd. Sound image localization device and sound image localization method
RU2306335C2 (ru) 1999-03-10 2007-09-20 Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Стволовые клетки и решетки, полученные из жировой ткани
US6777231B1 (en) 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20050153442A1 (en) 1999-03-10 2005-07-14 Adam Katz Adipose-derived stem cells and lattices
US20030082152A1 (en) 1999-03-10 2003-05-01 Hedrick Marc H. Adipose-derived stem cells and lattices
US7846465B1 (en) * 1999-05-28 2010-12-07 Fibrocell Science, Inc. Method of using autologous fibroblasts to promote healing of wounds and fistulas
US7670628B2 (en) 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
US6555374B1 (en) 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
US7078232B2 (en) * 1999-08-19 2006-07-18 Artecel, Inc. Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof
EP1257282A4 (en) 1999-12-06 2003-05-02 Gen Hospital Corp PANCREATIC STEM CELLS AND THEIR USE IN TRANSPLANTATION
JP4680483B2 (ja) 2001-02-23 2011-05-11 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 組織および臓器の治療および修復に用いるための幹細胞マトリックスの迅速な調製方法
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
BR0214029A (pt) 2001-11-09 2005-04-19 Artecel Sciences Inc Métodos e composições para o uso de células estromais para suportar células tronco embriÈnicas e adultas
AU2002346648A1 (en) * 2001-12-04 2003-06-17 Christopher J Woolverton Storage-stable fibrin sealant
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
WO2003070922A1 (en) * 2002-02-19 2003-08-28 Medipost Co., Ltd. Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
AU2003225791A1 (en) 2002-03-15 2003-09-29 Department Of Veterans Affairs, Rehabilitation R And D Service Methods and compositions for directing cells to target organs
WO2003106493A1 (en) * 2002-06-14 2003-12-24 Dyax Corporation Protein analysis
DE60318706T2 (de) 2002-06-14 2009-04-30 Cartela R & D Ab Marker für stammzellen und dessen verwendung
US20040101959A1 (en) * 2002-11-21 2004-05-27 Olga Marko Treatment of tissue with undifferentiated mesenchymal cells
JP2004190976A (ja) * 2002-12-12 2004-07-08 Sony Corp 熱輸送装置及び電子デバイス
JP2006517975A (ja) * 2003-02-13 2006-08-03 アンスロジェネシス コーポレーション 疾患、障害または症状を患っている個体を治療するための臍帯血の使用
ATE482725T1 (de) 2003-04-01 2010-10-15 Us Dept Of Veteran S Affaires Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen.
ES2265199B1 (es) 2003-06-12 2008-02-01 Cellerix, S.L. Celulas madre adultas multipotentes procedentes de condrocitos desdiferenciados y sus aplicaciones.
ES2552226T3 (es) 2003-06-27 2015-11-26 DePuy Synthes Products, Inc. Reparación y regeneración de cartílago y hueso utilizando células derivadas posparto
US7645229B2 (en) * 2003-09-26 2010-01-12 Armstrong David N Instrument and method for endoscopic visualization and treatment of anorectal fistula
WO2005035738A1 (en) 2003-10-07 2005-04-21 Biomaster Inc. Cell differentiation of adipose-derived precursor cells
US9631176B2 (en) 2003-11-04 2017-04-25 Biomaster, Inc. Method for preparing stem cells from fat tissue
WO2005062857A2 (en) 2003-12-24 2005-07-14 The Trustees Of Columbia University In The City Of New York Creation of a biological atrioventricular bypass to compensate for atrioventricular block
WO2005093044A1 (en) 2004-03-22 2005-10-06 Osiris Therapeutics, Inc. Mesenchymal stem cells and uses therefor
US20080095749A1 (en) 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
RU2252252C1 (ru) 2004-04-09 2005-05-20 Тепляшин Александр Сергеевич Способ выделения мезенхимальных стволовых клеток
ES2264862B8 (es) 2004-08-25 2017-01-20 Cellerix, S.L. Biomaterial para sutura.
US20060045872A1 (en) * 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
ES2313805B1 (es) 2004-10-04 2009-12-23 Cellerix, S.L. Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral.
US7732126B2 (en) 2004-09-03 2010-06-08 University Of Maryland, Baltimore Integrin CD18 is a novel stromal stem cell marker and functions to promote osteogenesis
WO2006110582A1 (en) 2005-04-08 2006-10-19 Xcyte Therapies, Inc. Compositions and methods for the treatment of burns and sepsis
MX342474B (es) 2005-09-23 2016-09-30 Cellerix Sl Poblaciones celulares con actividad inmunoreguladora, método de aislamiento y usos.
EP1795588A1 (en) 2005-12-07 2007-06-13 Cellerix, S.L. Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease
WO2008036374A2 (en) 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
EP2191835A4 (en) 2007-09-07 2011-12-14 Japan Chem Res THERAPEUTIC AND PROPHYLACTIC AGENTS FOR ARTHRITIS
KR20140107677A (ko) 2007-09-19 2014-09-04 플루리스템 리미티드 지방 또는 태반 조직 유래의 부착 세포 및 이의 치료 용도
KR20100076031A (ko) 2007-10-17 2010-07-05 티엑셀 Ｔｒ１ 세포, 중간엽 줄기 세포 및 이들의 용도
GB0814249D0 (en) 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
ES2345867B1 (es) 2009-04-03 2011-07-28 Fundacion Instituto Mediterraneo Para La Biotecnologia Y La Investigacion Sanitaria (Imabis) Celulas madre multipotentes derivadas de estroma de mesenterio.
DK2425844T3 (da) 2009-04-28 2014-06-16 Anterogen Co Ltd Autolog og allogen stromastamcellesammensætning, der stammer fra fedtvæv, til behandling af fistler
EP3150703A1 (en) 2009-07-09 2017-04-05 TiGenix, S.A.U. Cells for use in a method for treating inflammatory and/or immune disorders
WO2012095743A2 (en) 2011-01-12 2012-07-19 Cellerix Sa Methods and compositions for use in intralymphatic cellular therapies
WO2012123401A1 (en) 2011-03-11 2012-09-20 Tigenix, S.A. Cell populations having immunoregulatory activity, method for isolation and uses
US20140134140A1 (en) 2012-11-09 2014-05-15 Case Western Reserve University Mesenchymal stem cell compositions for the treatment of microbial infections
EP3581932A1 (en) 2013-03-15 2019-12-18 TiGenix, S.A.U. Lymphocyte biomarkers for determining the clinical response to cell therapy
EP3013943B1 (en) 2013-06-25 2019-04-10 TiGenix, S.A.U. Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
GB201604304D0 (en) 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease

Similar Documents

Publication Publication Date Title
JP2016116523A5 (enExample)
JP2008546397A5 (enExample)
Mafi et al. Adult mesenchymal stem cells and cell surface characterization-a systematic review of the literature
JP2010530214A5 (enExample)
NZ594848A (en) Use of adipose tissue-derived stromal stem cells in treating fistula
SA519401455B1 (ar) طريقة لعزل الخلايا الجذعية اللحمية المتوسطية من الغشاء السلوي للحبل السري باستخدام مستنبت خلايا متوسطية
SG158853A1 (en) Identification and isolation of multipotent cells from non-osteochondral mesenchymal tissue
JP2022027796A5 (enExample)
Coulson-Thomas et al. Extrinsic and intrinsic mechanisms by which mesenchymal stem cells suppress the immune system
HRP20180266T1 (hr) Postupak priprave osnovnog medija za kulturu mezenhimnih matičnih stanica, osnovni medij za kulturu mezenhimnih matičnih stanica, te terapijsko sredstvo za stanice koje se uzgaja i diferencira uz njegovu upotrebu
Klimczak et al. Mesenchymal stromal cells and tissue‐specific progenitor cells: Their role in tissue homeostasis
Han et al. The three-dimensional collagen scaffold improves the stemness of rat bone marrow mesenchymal stem cells
JP2014208682A5 (enExample)
JP2016523285A5 (enExample)
JP2017520583A5 (enExample)
HK1201293A1 (en) Adult mesenchymal stem cell (msc) compositions and methods for preparing the same
JP2020533021A5 (enExample)
JP2010518812A5 (enExample)
WO2012040465A3 (en) Multipotent stem cells and uses thereof
JP2015507921A5 (enExample)
RU2014129756A (ru) Индуцированные плюрипотентные стволовые клетки из клеток, полученных из ткани пуповины человека
Allickson et al. Human adult stem cells from menstrual blood and endometrial tissue
HRP20170216T1 (hr) Populacija ljudskih matičnih stanica vrata maternice i njihova uporaba
JP2020519645A5 (enExample)
AR112303A1 (es) Método para el tratamiento de un efecto secundario de la inmunoterapia